Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

NCT06039371 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
69
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Washington

Collaborators